Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
An open-label, U.S. and Canadian Phase IIa trial in 103 patients with ABSSSI due to Staphylococcus showed that twice-daily 200 mg oral AFN-1252 for 5-14 days led to an overall cure rate, defined as re...